Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:2517-2523

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pernerstorfer, T.
Right arrow Articles by Speiser, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pernerstorfer, T.
Right arrow Articles by Speiser, W.
Related Collections
Right arrow Anticoagulant mechanisms
Right arrow Coagulation and fibronolysis
Right arrow Platelets
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:2517-2523.)
© 1999 American Heart Association, Inc.


Thrombosis

Endotoxin-Induced Activation of the Coagulation Cascade in Humans

Effect of Acetylsalicylic Acid and Acetaminophen

T. Pernerstorfer; P. Stohlawetz; U. Hollenstein; L. Dzirlo; H.-G. Eichler; S. Kapiotis; B. Jilma; W. Speiser

From the Departments of Clinical Pharmacology (T.P., U.H., L.D., H.-G.E., B.J.), Anesthesiology and General Intensive Care Medicine (T.P.), and Transfusion Medicine (P.S.), and the Clinical Institute of Medical and Chemical Laboratory Diagnostics (S.K., W.S.), University of Vienna, Austria.

Correspondence to Dr Thomas Pernerstorfer, Department of Clinical Pharmacology, The Adhesion Group Elaborating Therapeutics (TARGET), University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria. E-mail thomas.pernerstorfer{at}univie.ac.at

Abstract—During Gram-negative septic shock, lipopolysaccharide (LPS, endotoxin) induces tissue factor (TF) expression. TF expression is mediated by nuclear factor {kappa}B and amplified by activated platelets. TF forms a highly procoagulant complex with activated coagulation factor VII (FVIIa). Hence, we hypothesized that aspirin, which inhibits LPS-induced, nuclear factor {kappa}B–dependent TF expression in vitro and platelet activation in vivo, may suppress LPS-induced coagulation in humans. Therefore, we studied the effects of aspirin on systemic coagulation activation in the established and controlled setting of the human LPS model. Thirty healthy volunteers were challenged with LPS (4 ng/kg IV) after intake of either placebo or aspirin (1000 mg). Acetaminophen (1000 mg) was given to a third group to control for potential effects of antipyresis. Neither aspirin nor acetaminophen inhibited LPS-induced coagulation. However, LPS increased the percentage of circulating TF+ monocytes by 2-fold. This increase was associated with a decrease in FVIIa levels, which reached a minimum of 50% 24 hours after LPS infusion. Furthermore, LPS-induced thrombin generation increased plasma levels of circulating polymerized, but not cross-linked, fibrin (ie, thrombus precursor protein), whereas levels of soluble fibrin were unaffected. In summary, a single 1000-mg dose of aspirin did not decrease LPS-induced coagulation. However, our study showed, for the first time, that LPS increases TF+ monocytes, substantially decreases FVIIa levels, and enhances plasma levels of thrombus precursor protein, which may be a useful marker of fibrin formation in humans.


Key Words: acetylsalicylic acid • acetaminophen • lipopolysaccharide • tissue factor • factor VIIa • coagulation




This article has been cited by other articles:


Home page
haematolHome page
F. Semeraro, C. T. Ammollo, N. Semeraro, and M. Colucci
Tissue factor-expressing monocytes inhibit fibrinolysis through a TAFI-mediated mechanism, and make clots resistant to heparins
Haematologica, June 1, 2009; 94(6): 819 - 826.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. N. Patel, S. H. Soubra, R. V. Bellera, J.-F. Dong, C. A. McMullen, A. R. Burns, and R. E. Rumbaut
Differential Role of von Willebrand Factor and P-Selectin on Microvascular Thrombosis in Endotoxemia
Arterioscler Thromb Vasc Biol, December 1, 2008; 28(12): 2225 - 2230.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Negrotto, E. Malaver, M. E. Alvarez, N. Pacienza, L. P. D'Atri, R. G. Pozner, R. M. Gomez, and M. Schattner
Aspirin and Salicylate Suppress Polymorphonuclear Apoptosis Delay Mediated by Proinflammatory Stimuli
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 972 - 979.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. E. Rumbaut, R. V. Bellera, J. K. Randhawa, C. N. Shrimpton, S. K. Dasgupta, J.-F. Dong, and A. R. Burns
Endotoxin enhances microvascular thrombosis in mouse cremaster venules via a TLR4-dependent, neutrophil-independent mechanism
Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1671 - H1679.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
E. Abraham
Effects of Recombinant Human Activated Protein C in Human Models of Endotoxin Administration
Proceedings of the ATS, October 1, 2005; 2(3): 243 - 247.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Steiner, W. S. Speidl, J. Pleiner, D. Seidinger, G. Zorn, C. Kaun, J. Wojta, K. Huber, E. Minar, M. Wolzt, et al.
Simvastatin Blunts Endotoxin-Induced Tissue Factor In Vivo
Circulation, April 12, 2005; 111(14): 1841 - 1846.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. Aras, A. Shet, R. R. Bach, J. L. Hysjulien, A. Slungaard, R. P. Hebbel, G. Escolar, B. Jilma, and N. S. Key
Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia
Blood, June 15, 2004; 103(12): 4545 - 4553.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. OSTERUD and E. BJORKLID
Role of Monocytes in Atherogenesis
Physiol Rev, October 1, 2003; 83(4): 1069 - 1112.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
W. C. Aird
The Hematologic System as a Marker of Organ Dysfunction in Sepsis
Mayo Clin. Proc., July 1, 2003; 78(7): 869 - 881.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Chia, M. Qadan, R. Newton, C. A. Ludlam, K. A.A. Fox, and D. E. Newby
Intra-Arterial Tumor Necrosis Factor-{alpha} Impairs Endothelium-Dependent Vasodilatation and Stimulates Local Tissue Plasminogen Activator Release in Humans
Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 695 - 701.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Fiorucci, A. Mencarelli, A. Meneguzzi, A. Lechi, A. Morelli, P. del Soldato, and P. Minuz
NCX-4016 (NO-Aspirin) Inhibits Lipopolysaccharide-Induced Tissue Factor Expression In Vivo: Role of Nitric Oxide
Circulation, December 10, 2002; 106(24): 3120 - 3125.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
K.-E. Eilertsen and B. Osterud
The central role of thromboxane and platelet activating factor receptors in ex vivo regulation of endotoxin-induced monocyte tissue factor activity in human whole blood
Innate Immunity, August 1, 2002; 8(4): 285 - 293.
[Abstract] [PDF]


Home page
BloodHome page
T. Pernerstorfer, U. Hollenstein, J.-B. Hansen, P. Stohlawetz, H.-G. Eichler, S. Handler, W. Speiser, and B. Jilma
Lepirudin blunts endotoxin-induced coagulation activation
Blood, March 1, 2000; 95(5): 1729 - 1734.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Pernerstorfer, U. Hollenstein, J.-B. Hansen, M. Knechtelsdorfer, P. Stohlawetz, W. Graninger, H.-G. Eichler, W. Speiser, and B. Jilma
Heparin Blunts Endotoxin-Induced Coagulation Activation
Circulation, December 21, 1999; 100(25): 2485 - 2490.
[Abstract] [Full Text] [PDF]